Company Description
NUGENE INTERNATIONAL, INC (NUGN) historically referred to NuGene International, Inc., but more recent company communications and SEC filings identify the issuer as Livento Group, Inc. with the same trading symbol on the OTC Pink market. According to multiple press releases and regulatory reports, Livento Group, Inc. is focused on acquiring and developing companies with what it describes as disruptive business models, particularly in film and television production, content, technology, robotics, and artificial intelligence.
Company materials state that Livento Group operates through several key business lines. One major area is BOXO Productions, described as a film and television production subsidiary. Press releases note that BOXO Productions works on feature films, television series, documentaries, and other entertainment projects, and that it holds ownership stakes in multiple completed and in‑production titles. For example, company news highlights BOXO’s involvement in the movie "Land of Bad" and references a portfolio of dozens of movie and content projects. Livento Group has also announced the launch of the BOXO Fund, presented as an investment product associated with BOXO Productions that focuses on financing film projects.
Another stated pillar is the Robotics and AI division, sometimes referred to as Livento Robotics & AI. Company communications describe this division as concentrating on technologies in robotics, artificial intelligence, the Internet of Things (IoT), and gaming. Within this division, Livento Group references two business lines: Elisee, described as a semi‑automated portfolio management tool used in investment contexts, and Novel‑Ti, described as a company focused on developing hardware and software products in IoT, robotics, AI, and gaming. Public materials emphasize that Elisee is used by professional investors and that Novel‑Ti has experience in building technology products in these domains.
Livento Group also highlights its relationship with Global Dot Logistics (GDL). Company news describes GDL as a logistics business and notes that Livento Group holds a stake in GDL. Disclosures mention that GDL has been undergoing an audit and that Livento Group views GDL as part of its broader strategy, including potential public listing plans for GDL. In various communications, the company positions its activities in film, content, robotics, AI, and logistics as part of a broader approach to building value through acquisitions and development of operating businesses.
Regulatory filings with the U.S. Securities and Exchange Commission identify the issuer as Livento Group, Inc. incorporated in Nevada. These filings show that the company continues to operate as a reporting entity and provide details on corporate actions, such as share issuances to officers and settlements of liabilities through stock. The filings confirm the legal name Livento Group, Inc. and its status as the registrant associated with the symbol NUGN in those documents.
While legacy references to NuGene International, Inc. appear in historical contexts, more recent press releases explicitly state that Livento Group Inc. was previously known as NuGene International, Inc. and that the company has pursued a corporate rebranding. One news release explains that the company submitted a name change to Livento Group Inc. to the Financial Industry Regulatory Authority (FINRA) and discussed a planned ticker symbol transition from NUGN to LIVG. That communication characterizes the rebranding as aligning the corporate identity with its focus on business models in AI/robotics, film, and movie production.
Company statements also describe steps related to OTC market status and regulatory processes. These include references to Form 211 submissions to FINRA, applications related to OTCQB status, and efforts to remove warning signs on OTC Markets. The company presents these actions as part of its efforts to improve transparency, regulatory compliance, and accessibility for investors in the over‑the‑counter market environment.
Overall, based on available public information, the entity historically known as NuGene International, Inc. and trading under the symbol NUGN is now described in company and regulatory materials as Livento Group, Inc., a Nevada corporation. Its stated focus is on acquiring and developing businesses in film and television production through BOXO Productions, technology and investment tools through its Robotics & AI division (including Elisee and Novel‑Ti), and logistics through its involvement with Global Dot Logistics.
Business Focus and Segments
Public communications from the company describe several main areas of activity:
- Film and Television Content: Through BOXO Productions, the company states that it acquires and develops feature films, television series, documentaries, and related entertainment content. It reports ownership interests in multiple completed and in‑production projects.
- Investment and Portfolio Tools: The Elisee product is described as a semi‑automated portfolio management tool used by professional investors and family offices, with company statements highlighting its performance relative to certain market indices over specified historical periods.
- Robotics, AI, IoT, and Gaming: Under the Novel‑Ti name and the broader Robotics & AI division, company materials describe activities in developing hardware and software products in robotics, AI, IoT, and gaming.
- Logistics: The company reports holding a stake in Global Dot Logistics and references that business in connection with logistics operations and potential public listing plans.
Corporate Evolution
One company press release states that Livento Group Inc. was previously known as NuGene International, Inc. and that it submitted a name change to FINRA, along with a planned change of its stock ticker symbol from NUGN to LIVG. The same communication characterizes this as a rebranding step and notes that the change would not alter the organization’s operations, management, or structure according to that release. As of the information provided, the symbol NUGN is still referenced in news and filings, while the company has communicated its intention to use the LIVG symbol following regulatory processes.
Regulatory Filings
Recent SEC filings identify the registrant as Livento Group, Inc., incorporated in Nevada, and provide details on specific corporate actions, such as share issuances to an officer under a subscription agreement and issuance of shares in connection with a liability settlement. These filings support the identification of Livento Group, Inc. as the reporting company associated with the historical NUGN symbol in the SEC’s records.
Relationship to Historical NuGene International, Inc.
The historical name NuGene International, Inc. appears in the context of the company’s prior identity. A press release explicitly states that Livento Group Inc. was previously known as NuGene International, Inc. and that the company has undertaken a name and ticker symbol change process. Based on that disclosure, NUGENE INTERNATIONAL, INC. is best understood in this context as the prior corporate name of the entity that is now described as Livento Group, Inc., rather than as a separate ongoing business with a distinct operating profile.
Stock Performance
Latest News
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Nugene Intl (NUGN) currently stands at 45.6 thousand shares, down 1.5% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 443.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Nugene Intl (NUGN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.